Skip to main content

Advertisement

Log in

Mechanisms of opioid-induced respiratory depression

  • Review Article
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Opioid-induced respiratory depression (OIRD), the primary cause of opioid-induced death, is the neural depression of respiratory drive which, together with a decreased level of consciousness and obstructive sleep apnea, cause ventilatory insufficiency. Variability of responses to opioids and individual differences in physiological and neurological states (e.g., anesthesia, sleep-disordered breathing, concurrent drug administration) add to the risk. Multiple sites can independently exert a depressive effect on breathing, making it unclear which sites are necessary for the induction of OIRD. The generator of inspiratory rhythm is the preBötzinger complex (preBötC) in the ventrolateral medulla. Other important brainstem respiratory centres include the pontine Kölliker-Fuse and adjacent parabrachial nuclei (KF/PBN) in the dorsal lateral pons, and the dorsal respiratory group in the medulla. Deletion of μ opioid receptors from neurons showed that the preBötC and KF/PBN contribute to OIRD with the KF as a respiratory modulator and the preBötC as inspiratory rhythm generator. Glutamatergic neurons expressing NK-1R and somatostatin involved in the autonomic function of breathing, and modulatory signal pathways involving GIRK and KCNQ potassium channels, remain poorly understood. Reversal of OIRD has relied heavily on naloxone which also reverses analgesia but mismatches between the half-lives of naloxone and opioids can make it difficult to clinically safely avoid OIRD. Maternal opioid use, which is rising, increases apneas and destabilizes neonatal breathing but opioid effects on maternal and neonatal respiratory circuits in neonatal abstinence syndrome (NAS) are not well understood. Methadone, administered to alleviate symptoms of NAS in humans, desensitizes rats to RD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Reproduced with permission from John Wiley and Sons (color figure online)

Fig. 5
Fig. 6

Similar content being viewed by others

References

Download references

Acknowledgements

The authors thank Nghia H. Pham for help in the preparation of Fig. 1.

Funding

No funding was received to assist in the preparation of this review.

Author information

Authors and Affiliations

Authors

Contributions

BAB conceived the study, undertook the literature review, researched and wrote the pathophysiology section and drafted the paper. MAR contributed to the literature review, clinical detail, and helped draft the review. Both authors approved the final draft of the review and agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Brian A. Baldo.

Ethics declarations

Conflict of interest

The authors declare that they have no known competing financial interests or personal relationships that influenced the work reported here.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Brian A. Baldo is retired. The positions and affiliations listed are those prior to retirement.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baldo, B.A., Rose, M.A. Mechanisms of opioid-induced respiratory depression. Arch Toxicol 96, 2247–2260 (2022). https://doi.org/10.1007/s00204-022-03300-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-022-03300-7

Keywords

Navigation